Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.80 |
| ▸ | POLB | P06746 | 2/20 | 0.80 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.63 |
| ▸ | CA1 | P00915 | 1/20 | 0.62 |
| ▸ | CA2 | P00918 | 1/20 | 0.62 |
| ▸ | CA9 | Q16790 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29601968 | 0.90 | KDM4E (0.98) | KDM4EPOLBCA1CA2CA9 | |
| SCHEMBL29461389 | 0.84 | KDM4E (0.67) | KDM4EPOLBCA1CA2CA9 | |
| SCHEMBL14987175 | 0.84 | KDM4E (0.74) | KDM4EPOLBCA1CA2CA9 | |
| SCHEMBL22118520 | 0.77 | CA1 (1.00) | KDM4EPOLBCA1CA2CA9 | |
| SCHEMBL14192408 | 0.75 | KAT8 (0.69) | POLBKMT2AALDH1A1MEN1 | |
| SCHEMBL28804425 | 0.74 | MAPT (0.64) | KDM4EKMT2AALDH1A1L3MBTL1MEN1 | |
| SCHEMBL8832776 | 0.72 | KAT8 (0.74) | POLBKMT2AALDH1A1L3MBTL1MEN1 | |
| SCHEMBL8282186 | 0.72 | KAT8 (0.65) | POLBKMT2ACA1CA2ALDH1A1 | |
| SCHEMBL12354953 | 0.72 | KAT8 (0.65) | POLBKMT2AALDH1A1MEN1 | |
| SCHEMBL28759581 | 0.71 | ATM (0.67) | KDM4EPOLBALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12546775-B2 | Peptides, reagents and methods for detecting food allergy | AllerGenis, Inc. (US) | 2026-02-10 | — | — | US | disclosed |
| US-20250388685-A1 | METHODS FOR TREATING CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS BY ADMINISTERING AN IL-4R ANTAGONIST | SANOFI BIOTECHNOLOGY (FR) | 2025-12-25 | — | — | US | disclosed |
| CN-118027033-A | HDAC6 inhibitor, preparation method thereof and application thereof in anti-inflammatory and ulcerative colitis | 四川大学 | 2024-05-14 | — | — | CN | disclosed |
| EP-4001920-A1 | PEPTIDES AND METHODS FOR DETECTING FOOD ALLERGY | AllerGenis, LLC (US) | 2022-05-25 | — | — | EP | disclosed |
| US-20220155296-A1 | Peptides, Reagents And Methods For Detecting Food Allergy | AllerGenis, Inc. | 2022-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12546775-B2 | Peptides, reagents and methods for detecting food allergy | HLA-DRB1, IL33, SERPINA6 | KDM4E 4464/4885POLB 3662/4885KMT2A 3029/4885 |
| US-20250388685-A1 | METHODS FOR TREATING CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS BY ADMINISTERING AN IL-4R ANTAGONIST | IL4, CCR4, IL1RN | KDM4E 1295/4885POLB 2737/4885KMT2A 3005/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.